Precision Optics (PEYE)

Overall impact
B (71)

Commentary

Precision Optics is a strong overall performer. With a 'B' rating of 70.9 for overall impact (83rd percentile compared to all companies), Precision Optics ranks 49th out of 155 industry peers, behind American Shared Hospital Services, Accuray, BioSig Technologies and 45 others, and ahead of Hologic, Avinger, Second Sight Medical Products and 103 others. On top material causes for Precision Optics's industry (Healthcare Equipment), Precision Optics performs well in Technology Innovation (95.5 score), Reduced Waste (95.1), Humane Treatment of Animals (95.6) and 4 other causes where it received an 'A' score and performs poorly in Reduced Green House Gas Emissions (30.4 score).
Impact
Cause PEYE
Peer rank
Overall impact

Log in to view this information

Impact trend

Change in rating for overall impact

Log in to view this information

Company
Employees
76
Sector
Health Care
Industry
Health Care Equipment & Supplies
Sub-industry
Health Care Equipment
SASB industry
Medical Equipment & Supplies
Headquarters
Ma, United States
Share classes
PEYE
Description
Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States and the European Economic Area. It offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians. The company also provides components and assemblies for industrial and military use. It markets its products to medical device companies. The company was incorporated in 1982 and is based in Gardner, Massachusetts.
Material causes
Ethos considers the following causes material for Precision Optics, based on its industry sub-industry Health Care Equipment. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.